Spontaneous Regression of Plasmablastic Lymphoma in an Immunocompetent Patient: Case Report and Review of the Literature

Table 1

Summary of clinical characteristic of spontaneous regression of PBL cases without antineoplastic therapy.

No.	Age/sex	Immune status	B symptom	Stage^a	Primary site	Nodal	Therapy	Follow up	Recurrence
1 [16]	35/male	Yes/HIV	No	I	Maxilla	No	HAART	1 month	No
2 [17]	55/female	Yes/HIV	N/A	N/A	Oral cavity	N/A	HAART	10 months	No
3 [18]	78/female	Yes/MTX treatment	N/A	II	Buccal mucosa	Yes (cervical)	Decrease dose of MTX	2 years	No
4 [19]	80/male	No	No	I	Maxilla	No	No	5 months	No
5 [20]	80/male	No	No	I	Gingiva	No	No	N/A	No
6 [21]	66/female	Yes/HIV	No	I	Maxilla	No	HAART	12 months	No
7 [22]	69/male	Yes/MTX^b treatment	No	IV	N/A^c	No	Stop MTX	12 weeks	No
8 [23]	69/male	No	No	I	Gingiva	N/A	No	2 years	No
9	61/male	No	No	I	Nasal	No	No	4 years	No

^aAssessed using Ann Arbor staging. ^bMTX, methotrexate. ^cN/A, not available.